About artivion inc. - AORT
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
AORT At a Glance
Artivion, Inc.
1655 Roberts Boulevard NW
Kennesaw, Georgia 30144-3632
| Phone | 1-770-419-3355 | Revenue | 441.33M | |
| Industry | Medical Specialties | Net Income | 9.76M | |
| Sector | Health Technology | 2025 Sales Growth | 13.588% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,800 | |
| View SEC Filings |
AORT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 220.445 |
| Price to Sales Ratio | 4.874 |
| Price to Book Ratio | 4.868 |
| Price to Cash Flow Ratio | 53.94 |
| Enterprise Value to EBITDA | 41.394 |
| Enterprise Value to Sales | 5.313 |
| Total Debt to Enterprise Value | 0.11 |
AORT Efficiency
| Revenue/Employee | 245,183.333 |
| Income Per Employee | 5,420.556 |
| Receivables Turnover | 4.257 |
| Total Asset Turnover | 0.527 |
AORT Liquidity
| Current Ratio | 2.989 |
| Quick Ratio | 2.079 |
| Cash Ratio | 0.639 |
AORT Profitability
| Gross Margin | 61.281 |
| Operating Margin | 7.746 |
| Pretax Margin | 3.349 |
| Net Margin | 2.211 |
| Return on Assets | 1.166 |
| Return on Equity | 2.694 |
| Return on Total Capital | 1.381 |
| Return on Invested Capital | 1.463 |
AORT Capital Structure
| Total Debt to Total Equity | 57.674 |
| Total Debt to Total Capital | 36.578 |
| Total Debt to Total Assets | 29.217 |
| Long-Term Debt to Equity | 56.274 |
| Long-Term Debt to Total Capital | 35.69 |